CRBU
Price
$1.26
Change
+$0.17 (+15.60%)
Updated
Jun 6 closing price
Capitalization
101.38M
65 days until earnings call
LYEL
Price
$12.76
Change
+$1.30 (+11.34%)
Updated
Jun 6 closing price
Capitalization
169.7M
59 days until earnings call
Interact to see
Advertisement

CRBU vs LYEL

Header iconCRBU vs LYEL Comparison
Open Charts CRBU vs LYELBanner chart's image
Caribou Biosciences
Price$1.26
Change+$0.17 (+15.60%)
Volume$2.03M
Capitalization101.38M
Lyell Immunopharma
Price$12.76
Change+$1.30 (+11.34%)
Volume$383.86K
Capitalization169.7M
CRBU vs LYEL Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. LYEL commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and LYEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CRBU: $1.12 vs. LYEL: $0.41)
Brand notoriety: CRBU and LYEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 148% vs. LYEL: 45%
Market capitalization -- CRBU: $101.38M vs. LYEL: $169.7M
CRBU [@Biotechnology] is valued at $101.38M. LYEL’s [@Biotechnology] market capitalization is $169.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileLYEL’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • LYEL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while LYEL’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 4 bearish.
  • LYEL’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а +10.34% price change this week, while LYEL (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

LYEL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYEL($170M) has a higher market cap than CRBU($101M). CRBU YTD gains are higher at: -29.560 vs. LYEL (-35.938). CRBU has more cash in the bank: 210M vs. LYEL (22M). CRBU has less debt than LYEL: CRBU (26.5M) vs LYEL (48.9M).
CRBULYELCRBU / LYEL
Capitalization101M170M59%
EBITDA-162.69MN/A-
Gain YTD-29.560-35.93882%
P/E RatioN/AN/A-
Revenue9.99MN/A-
Total Cash210M22M955%
Total Debt26.5M48.9M54%
TECHNICAL ANALYSIS
Technical Analysis
CRBULYEL
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
77%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with FATE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+2.75%
FATE - CRBU
54%
Loosely correlated
+4.10%
CRSP - CRBU
54%
Loosely correlated
-0.92%
CCCC - CRBU
53%
Loosely correlated
-3.08%
BEAM - CRBU
51%
Loosely correlated
-0.88%
NTLA - CRBU
48%
Loosely correlated
+3.59%
More

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with PRME. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-0.15%
PRME - LYEL
42%
Loosely correlated
N/A
TYRA - LYEL
42%
Loosely correlated
+1.93%
RCKT - LYEL
42%
Loosely correlated
+6.44%
NTLA - LYEL
41%
Loosely correlated
+3.59%
CRBU - LYEL
41%
Loosely correlated
+2.75%
More